Impulsive and compulsive behaviors have become increasingly associated with Parkinson disease (PD) and treatment. Recently, the International Parkinson’s and Movement Disorder Society commissioned a task force to assess currently available screening tools and rating scales in order to make recommendations regarding their utility, as well as to inform future directions in scale development and validation.
Impulsive and compulsive behaviors (ICBs) have become increasingly associated with Parkinson disease (PD) and treatment. Recently, the International Parkinson’s and Movement Disorder Society commissioned a task force to assess currently available screening tools and rating scales in order to make recommendations regarding their utility, as well as to inform future directions in scale development and validation.
Members of the task force conducted a systematic review on available screening tools and scales used in PD studies to detect a range of impulse control disorders (ICDs), including compulsive medication use, pathological gambling, hypersexuality, binge eating, and reckless driving, among others.
The group identified 50 scales used to measure the severity of ICDs in studies of patients with PD. Study investigators assessed each scale for descriptive and clinometric properties, availability content, use, acceptability, and overall impression in patients with PD. The group recommended a scale if it had been applied to PD populations, contained data on the use of the scale in more than 1 cohort, and if the scale was determined as adequate for either screening purposes, assessing symptom severity, or measuring responsiveness to change.
The group reached a few recommendations on which scale to use:
The study authors suggest that early identification of ICDs can help guide treatment decisions in patients with PD, as the presence of multiple ICDs in this population may be associated with poorer quality of life, depression, or treatment resistance. Going forward, the researchers recommend that “further testing of established scales against gold standard diagnostic criteria is urgently required for all other individual ICBs in PD,” wrote the authors.
Reference
Evans A, Okai D, Weintraub D, et al. Members of the International Parkinson and Movement Disorder Society (IPMDS) rating scales review committee. Scales to assess impulsive and compulsive behaviors in Parkinson’s disease: critique and recommendations. Mov Disord. 2019;34(6):791-798.
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Early Involvement Critical in Treating Immunotherapy-Induced Overlap Syndrome
April 19th 2024A series of case studies reveals the importance of early diagnosis and involvement of special teams of clinicians when dealing with potential cases of overlap syndrome, which encompasses myocarditis, myasthenia gravis, and immune checkpoint inhibitor–related myositis.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen